circRNA basic information
circBase ID: hsa_circ_0007334
Name: hsa_circ_MBOAT2
Synonym: circMBOAT2
Host Gene: MBOAT2
Genomic location(hg19): chr2:9083315-9098771:-
Genomic location(hg38): chr2:8943186-8958642:-
Subcellular localization: nucleus and cytoplasm
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0003210
MONDO name: intrahepatic cholangiocarcinoma
Disease details: intrahepatic cholangiocarcinoma / ICC
Disease DO ID:
4928
Disease MeSH ID:
-
Disease NCIt ID:
C35417
Disease ICD11 ID:
1253728223; 387909164
Disease OMIM ID:
-
Species: Human
Species details: Homo sapiens
Tissue specimen:

ICC tissues; adjacent normal tissues

Cell lines:

RBE; HCCC-9810; HuCCT1; CCLP1; QBC-939; QBC-939; H69

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: PTBP1, FASN, AGO2
Associated microRNA: -
Biological function: Promotes ICC cell proliferation, colony formation, tumor growth and metastasis; inhibits apoptosis and G0/G1 arrest; promotes lipid metabolism reprogramming (especially unsaturated fatty acids) and reduces oxidative stress/ROS and lipid peroxidation.
Molecular mechanism: Binds PTBP1 and protects it from ubiquitin/proteasome-dependent degradation, thereby promoting PTBP1-mediated cytoplasmic export of FASN mRNA to increase FASN translation; regulates lipid metabolic profile (unsaturated fatty acids) and redox homeostasis.
Biological pathway or process:

lipid metabolism (promotes); oxidative phosphorylation (other); ferroptosis (inhibits); NF-kappaB (inhibits); apoptosis (inhibits); cell cycle (promotes); proliferation (promotes); metastasis (promotes); other pathway/process (other)

Detected method:
Q
S
Validation methods:

RNA-seq; RT-qPCR; Back-Splice Junction PCR / divergent primers PCR; Sanger Sequencing; RNase R Treatment; FISH / smFISH; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; Transfection; CCK8; EdU Staining; Colony Formation Assay; Annexin V/PI Flow Cytometry; Cell Cycle Assay; In Vivo Animal Model; IHC (Immunohistochemistry); Western Blot; RNA Pull-Down; RIP (RNA Immunoprecipitation); Bioinformatics Analysis; Flow Cytometry(Non-apoptosis/cycle)

Clinical significance:

Frequently upregulated in ICC tissues, positively correlated with malignant features and tumor size, and higher expression was slightly correlated with shorter OS / predicts poor survival.

Description:

circMBOAT2 (hsa_circ_0007334) is upregulated in intrahepatic cholangiocarcinoma and promotes tumor growth and metastatic phenotypes. It acts mainly by binding and stabilizing PTBP1 (reducing PTBP1 ubiquitin/proteasome degradation), thereby enhancing PTBP1-mediated cytoplasmic export of FASN mRNA and increasing FASN translation. This reprograms lipid metabolism toward unsaturated fatty acids and helps maintain redox homeostasis (lower ROS/lipid peroxidation), contributing to ICC progression and suggesting a potential therapeutic target.

Confidence score:

0.8661

Other information
Title:

CircRNA MBOAT2 promotes intrahepatic cholangiocarcinoma progression and lipid metabolism reprogramming by stabilizing PTBP1 to facilitate FASN mRNA cytoplasmic export.

Journal: Cell death & disease
Published: 2023
PubMed ID: 36635270
Study type:

combined biological and clinical study

Data availability: The datasets generated and/or analyzed during the current study are available from the corresponding author upon reasonable request.
Code availability: -